Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current Assets:
Cash & cash equivalents	$ 162,152	$ 766,189
Certificates of deposit		244,971
Accounts Receivable	232,602	137,499
Notes Receivable (inclusive of $452,775 in advances to Helomics)	497,276	667,512
Inventories	241,066	265,045
Prepaid Expense and other assets	318,431	289,966
Total Current Assets	1,451,527	2,371,182
Notes Receivable	1,112,524	1,070,000
Fixed Assets, net	180,453	87,716
Intangibles, net	964,495	95,356
Total Assets	3,708,999	3,624,254
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts Payable	445,689	140,462
Notes Payable – Bridge Loan Net of Discount	1,327,942
Notes Payable – Net of Discount	306,972
Accrued Expenses	1,279,114	785,215
Derivative Liability	272,745
Deferred Revenue	23,065	6,663
Total Current Liabilities	3,655,527	932,340
Total Liabilities	3,655,527	932,340
Stockholders’ Equity:
Common Stock, $.01 par value, 50,000,000 authorized, 14,091,748 and 6,943,283 outstanding	140,917	69,432
Additional paid-in capital	(63,019,708)	(55,636,680)
Accumulated deficit	63,107,945	53,021,469
Total Stockholders' Equity	53,472	2,691,914
Total Liabilities and Stockholders' Equity	3,708,999	3,624,254
Series B Convertible Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock	792	792
Series C Convertible Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock		$ 6,479